Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
(NQ:
)
N/A
UNCHANGED
Last Price
/ Updated:
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
-
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Top News
More News
Antigenics Changes Company Name to Agenus
January 06, 2011
Reflects Diversity of Product Portfolio; Emphasis on Partnership and Collaboration
Read More
from
GlobeNewswire News Releases
SmarTrend Watching for Potential Pullback in Shares of Antigenics After 4.76% Gain (AGEN)
January 06, 2011
from
Comtex SmarTrend® News Briefs
More News
Read More
Volume Spike Detected in Shares of Antigenics as They Move Higher on 3.2x Above-Average Volume (AGEN)
January 05, 2011
from
Comtex SmarTrend® News Briefs
Antigenics: Stock To Watch: Up 3% (AGEN)
January 03, 2011
from
Comtex SmarTrend® News Briefs
Antigenics Rises 4.95% on Heavy Volume: Watch For Potential Pullback (AGEN)
December 29, 2010
from
Comtex SmarTrend® News Briefs
Antigenics: Stock To Watch: Up 3% (AGEN)
December 28, 2010
from
Comtex SmarTrend® News Briefs
Shares of Antigenics are Moving Higher on 2.1x Above-Average Volume (AGEN)
December 27, 2010
from
Comtex SmarTrend® News Briefs
Mentor Capital to Expand Funding Bridge for Valley of Death Cancer Companies in 2011
December 21, 2010
from
Business Wire News Releases
Mentor Capital Cancer Immunotherapy Index Gains on Medicare Advisory Committee Approval of $93,000 Provenge Immunotherapy Treatment by Dendreon for Prostate Cancer
November 24, 2010
from
Business Wire News Releases
Celldex cancer vaccine meets goal in midstage trial
November 20, 2010
category
companyNews
from
Reuters: Company News
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here